Literature DB >> 18258203

Mimicking phosphorylation of Ser-74 on human deoxycytidine kinase selectively increases catalytic activity for dC and dC analogues.

Theresa McSorley1, Stephan Ort, Saugata Hazra, Arnon Lavie, Manfred Konrad.   

Abstract

Intracellular phosphorylation of dCK on Ser-74 results in increased nucleoside kinase activity. We mimicked this phosphorylation by a Ser-74-Glu mutation in bacterially produced dCK and investigated kinetic parameters using various nucleoside substrates. The S74E mutation increases the k(cat) values 11-fold for dC, and 3-fold for the anti-cancer analogues dFdC and AraC. In contrast, the rate is decreased for the purine substrates. In HEK293 cells, we found that by comparing transiently transfected dCK(S74E)-GFP and wild-type dCK-GFP, mimicking the phosphorylation of Ser-74 has no effect on cellular localisation. We note that phosphorylation may represent a mechanism to enhance the catalytic activity of the relatively slow dCK enzyme.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18258203      PMCID: PMC2636680          DOI: 10.1016/j.febslet.2008.01.048

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  21 in total

1.  Human deoxycytidine kinase is located in the cell nucleus.

Authors:  M Johansson; S Brismar; A Karlsson
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

2.  Activation of deoxycytidine kinase by deoxyadenosine: implications in deoxyadenosine-mediated cytotoxicity.

Authors:  Gergely Keszler; Szula Virga; Tatjana Spasokoukotskaja; Pal I Bauer; Maria Sasvari-Szekely; Maria Staub
Journal:  Arch Biochem Biophys       Date:  2005-04-01       Impact factor: 4.013

3.  Identification of in vivo phosphorylation sites on human deoxycytidine kinase. Role of Ser-74 in the control of enzyme activity.

Authors:  Caroline Smal; Didier Vertommen; Luc Bertrand; Sandrine Ntamashimikiro; Mark H Rider; Eric Van Den Neste; Françoise Bontemps
Journal:  J Biol Chem       Date:  2005-12-16       Impact factor: 5.157

4.  Comparison of fixation protocols for adherent cultured cells applied to a GFP fusion protein of the epidermal growth factor receptor.

Authors:  R Brock; I H Hamelers; T M Jovin
Journal:  Cytometry       Date:  1999-04-01

5.  Positive regulation of deoxycytidine kinase activity by phosphorylation of Ser-74 in B-cell chronic lymphocytic leukaemia lymphocytes.

Authors:  Caroline Smal; Eric Van Den Neste; Marie Maerevoet; Xavier Poiré; Ivan Théate; Françoise Bontemps
Journal:  Cancer Lett       Date:  2007-03-09       Impact factor: 8.679

6.  Long PDE4 cAMP specific phosphodiesterases are activated by protein kinase A-mediated phosphorylation of a single serine residue in Upstream Conserved Region 1 (UCR1).

Authors:  Simon J MacKenzie; George S Baillie; Ian McPhee; Carolynn MacKenzie; Rachael Seamons; Theresa McSorley; Jenni Millen; Matthew B Beard; Gino van Heeke; Miles D Houslay
Journal:  Br J Pharmacol       Date:  2002-06       Impact factor: 8.739

7.  The intracellular localization of deoxycytidine kinase.

Authors:  P Hatzis; A S Al-Madhoon; M Jüllig; T G Petrakis; S Eriksson; I Talianidis
Journal:  J Biol Chem       Date:  1998-11-13       Impact factor: 5.157

8.  Regulation of brefeldin A-inhibited guanine nucleotide-exchange protein 1 (BIG1) and BIG2 activity via PKA and protein phosphatase 1gamma.

Authors:  Fuminobu Kuroda; Joel Moss; Martha Vaughan
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-21       Impact factor: 11.205

9.  ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage.

Authors:  Shuhei Matsuoka; Bryan A Ballif; Agata Smogorzewska; E Robert McDonald; Kristen E Hurov; Ji Luo; Corey E Bakalarski; Zhenming Zhao; Nicole Solimini; Yaniv Lerenthal; Yosef Shiloh; Steven P Gygi; Stephen J Elledge
Journal:  Science       Date:  2007-05-25       Impact factor: 47.728

10.  Structure of human dCK suggests strategies to improve anticancer and antiviral therapy.

Authors:  Elisabetta Sabini; Stephan Ort; Christian Monnerjahn; Manfred Konrad; Arnon Lavie
Journal:  Nat Struct Biol       Date:  2003-07
View more
  16 in total

1.  Structural and kinetic characterization of human deoxycytidine kinase variants able to phosphorylate 5-substituted deoxycytidine and thymidine analogues .

Authors:  Saugata Hazra; Stephan Ort; Manfred Konrad; Arnon Lavie
Journal:  Biochemistry       Date:  2010-08-10       Impact factor: 3.162

2.  Cell fate control gene therapy based on engineered variants of human deoxycytidine kinase.

Authors:  Anton Neschadim; James C M Wang; Takeya Sato; Daniel H Fowler; Arnon Lavie; Jeffrey A Medin
Journal:  Mol Ther       Date:  2012-01-24       Impact factor: 11.454

3.  Post-translational phosphorylation of serine 74 of human deoxycytidine kinase favors the enzyme adopting the open conformation making it competent for nucleoside binding and release.

Authors:  Saugata Hazra; Andrzej Szewczak; Stephan Ort; Manfred Konrad; Arnon Lavie
Journal:  Biochemistry       Date:  2011-03-16       Impact factor: 3.162

Review 4.  Enzymes to die for: exploiting nucleotide metabolizing enzymes for cancer gene therapy.

Authors:  Andressa Ardiani; Adam J Johnson; Hongmei Ruan; Marilyn Sanchez-Bonilla; Kinta Serve; Margaret E Black
Journal:  Curr Gene Ther       Date:  2012-04-01       Impact factor: 4.391

5.  A new pyrimidine-specific reporter gene: a mutated human deoxycytidine kinase suitable for PET during treatment with acycloguanosine-based cytotoxic drugs.

Authors:  Yury Likar; Juan Zurita; Konstantin Dobrenkov; Larissa Shenker; Shangde Cai; Anton Neschadim; Jeffrey A Medin; Michel Sadelain; Hedvig Hricak; Vladimir Ponomarev
Journal:  J Nucl Med       Date:  2010-09       Impact factor: 10.057

6.  Phosphorylation of Leukotriene C4 Synthase at Serine 36 Impairs Catalytic Activity.

Authors:  Shabbir Ahmad; A Jimmy Ytterberg; Madhuranayaki Thulasingam; Fredrik Tholander; Tomas Bergman; Roman Zubarev; Anders Wetterholm; Agnes Rinaldo-Matthis; Jesper Z Haeggström
Journal:  J Biol Chem       Date:  2016-06-30       Impact factor: 5.157

7.  Extending thymidine kinase activity to the catalytic repertoire of human deoxycytidine kinase.

Authors:  Saugata Hazra; Elisabetta Sabini; Stephan Ort; Manfred Konrad; Arnon Lavie
Journal:  Biochemistry       Date:  2009-02-17       Impact factor: 3.162

8.  The apoptotic effects of toosendanin are partially mediated by activation of deoxycytidine kinase in HL-60 cells.

Authors:  Jianming Ju; Zhichao Qi; Xueting Cai; Peng Cao; Yan Huang; Shuzhen Wang; Nan Liu; Yijun Chen
Journal:  PLoS One       Date:  2012-12-27       Impact factor: 3.240

9.  Retrovolution: HIV-driven evolution of cellular genes and improvement of anticancer drug activation.

Authors:  Paola Rossolillo; Flore Winter; Etienne Simon-Loriere; Sarah Gallois-Montbrun; Matteo Negroni
Journal:  PLoS Genet       Date:  2012-08-23       Impact factor: 5.917

Review 10.  New insights into the synergism of nucleoside analogs with radiotherapy.

Authors:  Michael W Lee; William B Parker; Bo Xu
Journal:  Radiat Oncol       Date:  2013-09-26       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.